Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Microdermabrasion + tacrolimus + Elocom vs pimecrolimus + Elocom in vitiligo
IRCT201212059800N3Phase 2Completed
- Sponsor
- Tehran University of Medical Sciences
- Start
- Aug 2013
- Modality
- RNA-Targeting Small Molecules → Nucleic Acid-Directed Small Molecules → Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised trial in Vitiligo comparing Microdermabrasion + tacrolimus ointment + Elocom ointment with Pimecrolimus ointment + Elocom ointment (2 arms). Started Aug 2013; status: completed.
02
Drugs
tacrolimuspimecrolimusmometasone
03
Conditions
Vitiligo
Beyond the preview
Go deeper on IRCT201212059800N3.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT201212059800N3.